Close Menu

More articles about Hematology/Coagulation

The company aims to wrap up field trials for the system by the end of this year and will seek European regulatory clearance thereafter.

The blood grouping reagents for extended phenotype testing cover more than 99 percent of the most commonly tested blood-group antigens.  

The company said that the funds will allow it to take its ReadyPlex rapid blood group genotyping assays into clinical trials and commercialization.

A technician conducting a test at Grifols' CLIA lab

The firm's president of global diagnostics marketing said that recent revenue growth comes as a result of multiple initiatives implemented in recent years.

Under the 10-year deal, CoLabs will have access to Immucor's automated instrumentation and data-management technology.

Streck has inked a distribution agreement with Innovative Medical Solutions for its portfolio of controls, cell stabilization, and molecular products.

The commercial future of the test is uncertain, but one of its developers said that work to develop it demonstrates even mature technologies can have new clinical value. 

Axon will distribute Biosurfit's POC instrument as part of the deal, which follows earlier agreements between the two firms covering Austria, Croatia, Slovakia, the Czech Republic, and Slovenia.

The kit is designed to be used on the same platform as Grifols' other molecular typing platforms and can provide results within four hours of DNA extraction.

The analyzer, part of Abbott's Alinity portfolio, is designed to streamline clinical workflows for high-volume laboratories and hospital systems.  

Under the agreement, Beckman Coulter would distribute Grifols' hemostasis instruments, reagents, and consumables and have systems available early next year.

Streck and Nordic BioSite have signed a distribution agreement for Streck's full portfolio of cell stabilization, molecular, and core products.

The enhancements provide labs with more options to automate the release of test results to laboratory information systems. 

Roche's Bluetooth-enabled meter gives patients the option to bypass frequent trips to the clinic in favor of doing anticoagulation testing at home.   

The assay runs on the Procleix Panther system and detects B. microti, B. duncani, B. divergens, and B. venatorum parasites that can be transmitted by tick bites or blood donation. 

The firm's SteriPath device can reduce contamination tenfold, and it has hired a new chief commercialization officer to expand its reach in the preanalytical diagnostics space. 

The parties reached a settlement agreement on the case, which alleged Alere sold systems knowing that they could cause patients serious harm, or even death.

The fully-automated system features technology to measure blood volumes in each culture bottle to ensure compliance with accreditation guidelines.

The firms said that the kit will employ microparticle biomarker technology to identify and monitor patients at high risk of coagulation complications.      

The firm said that its diagnostic instrument provides hematology results in six minutes, and it may speed time to patient treatments, as well as accelerate product sales.